Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street's Insights on Key Metrics

The upcoming report from ResMed (RMD) is expected to reveal quarterly earnings of $2.68 per share, indicating an increase of 10.3% compared to the year-ago period. Analysts forecast revenues of $1.39 billion, representing an increase of 8.3% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.2% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reve ...